Malady Kyle

Malady Kyle serves as the EVP and Group CEO of VZ Business at Verizon Communications Inc, overseeing significant operations within the company. His recent insider trading activity, documented through SEC Form 4 filings, reveals a focused pattern of sale activity primarily involving Verizon (VZ) and DexCom Inc (DXCM). Between May 12, 2025, and July 6, 2026, Kyle disclosed a total of 36 transactions, with sales ranging from $855.2K to $832.4K, and the largest disclosed move being a grant/exercise valued at approximately $2.8 million on February 13, 2026.